| Recruiting | The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions NCT07278609 | McGill University Health Centre/Research Institute of the McGill University Health Centre | — |
| Recruiting | Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis NCT07301892 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | — |
| Not Yet Recruiting | Mass Spectrometry-based Immune Profiling in Autoimmune Diseases NCT07188285 | Peking University People's Hospital | — |
| Recruiting | Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic NCT06779799 | University Hospital, Brest | — |
| Recruiting | MEMRI and Kidney Disease NCT06698614 | University of Edinburgh | — |
| Recruiting | Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children NCT06321601 | Amgen | Phase 3 |
| Recruiting | Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms NCT02638701 | University of California, San Francisco | Phase 1 / Phase 2 |
| Unknown | How Sirtuin Levels Change During Behçet Disease NCT06266247 | Karamanoğlu Mehmetbey University | N/A |
| Recruiting | Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting NCT05012033 | Imperial College London | — |
| Recruiting | Longitudinal Study for Central Nervous System Vasculitis NCT05734404 | University of Pennsylvania | — |
| Recruiting | Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases NCT05383339 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis NCT05565885 | University Hospital, Tours | — |
| Completed | FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis NCT05000138 | Jewish General Hospital | — |
| Recruiting | Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases NCT05251415 | University Hospital, Toulouse | — |
| Unknown | National Vaccine Adverse Event Reporting Survey and Etiology NCT05095844 | Neuroganics LLC | — |
| Completed | Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 NCT05115370 | University of Nottingham | — |
| Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Init NCT05635266 | Sanguine Biosciences | — |
| Recruiting | Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compare NCT04629144 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Unknown | A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmu NCT05263817 | Zhejiang University | EARLY_Phase 1 |
| Completed | CXCR4-PET/CT for Diagnosing Giant Cell Arteritis NCT05604482 | Matthias Fröhlich | N/A |
| Recruiting | Longitudinal Study for Relapsing Polychondritis NCT04919538 | University of Pennsylvania | — |
| Unknown | Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc NCT05292456 | Hacettepe University | — |
| Completed | Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy NCT04554290 | Central Hospital, Nancy, France | — |
| Recruiting | Prospective Longitudinal Cohort Study of Vasculitis Patients NCT04413331 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Vascular Lab Resource (VLR) Biorepository NCT05628948 | The Cleveland Clinic | — |
| Withdrawn | Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders NCT02418273 | Indiana University | Phase 1 / Phase 2 |
| Unknown | Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit NCT04022655 | University of Göttingen | — |
| Recruiting | Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis NCT04006535 | Benjamin Terrier | — |
| Terminated | Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases NCT03937856 | Johns Hopkins University | N/A |
| Unknown | JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibi NCT04294771 | Groupe Hospitalier Pitie-Salpetriere | — |
| Completed | TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-u NCT03804112 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Enrolling By Invitation | Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid A NCT03755245 | Turku University Hospital | N/A |
| Unknown | The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children NCT03692416 | Assiut University | Phase 3 |
| Completed | Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis NCT03693586 | Hospital General de Mexico | — |
| Completed | Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease NCT03371095 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Unknown | Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology NCT03459274 | Cedars-Sinai Medical Center | — |
| Completed | Journey of Patients With Vasculitis From First Symptom to Diagnosis NCT03410290 | University of Pennsylvania | — |
| Recruiting | Clinical Transcriptomics in Systemic Vasculitis (CUTIS) NCT03004326 | Peter Merkel | — |
| Completed | Endothelin Antagonism in ANCA Vasculitis NCT02062346 | University of Edinburgh | N/A |
| Recruiting | Vasculitis Pregnancy Registry NCT02593565 | University of Pennsylvania | — |
| Unknown | Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases? NCT02498808 | University of Oxford | — |
| Completed | Phenomics in Autoimmune and Inflammatory Diseases NCT02466217 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | The ANCA Vasculitis Questionnaire (AAV-PRO©) NCT02507024 | University of Pennsylvania | — |
| Withdrawn | Pregnancy and Medically Assisted Conception in Rare Diseases NCT02450396 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Impact of Vasculitis on Employment and Income NCT02476292 | University of South Florida | — |
| Completed | Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis NCT03765424 | University of Aarhus | — |
| Unknown | Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection NCT02261662 | Tanta University | N/A |
| Active Not Recruiting | The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach NCT01933724 | University of South Florida | Phase 3 |
| Unknown | Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis NCT02856243 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Immunogenicity and Safety of Vaccinations in Immunocompromised Persons NCT01947465 | University of Zurich | — |
| Completed | Belimumab in Remission of VASculitis NCT01663623 | Human Genome Sciences Inc., a GSK Company | Phase 3 |
| Completed | PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases NCT02084147 | Case Comprehensive Cancer Center | N/A |
| Completed | Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Re NCT02240888 | Region Skane | N/A |
| Completed | A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis NCT01363388 | Amgen | Phase 2 |
| Unknown | Alemtuzumab for ANCA Associated Refractory Vasculitis NCT01405807 | Cambridge University Hospitals NHS Foundation Trust | Phase 4 |
| Completed | Positron Emission Tomography of Infection and Vasculitis NCT01878721 | Turku University Hospital | — |
| Completed | Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis NCT01795456 | The Cleveland Clinic | — |
| Completed | Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses NCT01170936 | Charite University, Berlin, Germany | Phase 2 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants NCT05984251 | Amgen | Phase 1 |
| Recruiting | National Registry of Rare Kidney Diseases NCT06065852 | UK Kidney Association | — |
| Completed | The CARRA Registry NCT01697254 | Duke University | — |
| Completed | Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis NCT00414128 | Cambridge University Hospitals NHS Foundation Trust | Phase 2 / Phase 3 |
| Completed | The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease NCT00331331 | National Eye Institute (NEI) | — |
| Completed | Improving the Quality of Patient Care by Using a Clinical Expert System. NCT00430755 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | N/A |
| Completed | Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years NCT00307671 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Recruiting | A Real-World Registry of Chronic Wounds and Ulcers NCT02280733 | U.S. Wound Registry | — |
| Completed | Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis NCT00104299 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 / Phase 3 |
| Completed | Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) NCT00103792 | University Medical Center Groningen | Phase 3 |
| Terminated | Hematopoietic Stem Cell Support in Vasculitis NCT00278512 | Northwestern University | Phase 1 |
| Completed | MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis NCT00301652 | Nanjing University School of Medicine | N/A |
| Terminated | Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculit NCT00128895 | University Medical Center Groningen | Phase 4 |
| Completed | Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis NCT00029107 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation NCT00005928 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related V NCT00004567 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Etanercept to Treat Wegener's Granulomatosis NCT00001901 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions NCT00001764 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis NCT00001761 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Absorption of Corticosteroids in Children With Juvenile Dermatomyositis NCT00004357 | Northwestern University | Phase 2 |
| Completed | Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis NCT00001541 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides NCT00001473 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity NCT03941184 | Mayo Clinic | — |
| Completed | Steroids and Methotrexate to Treat Systemic Vasculitis NCT00001256 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Treatment of Wegener's Granulomatosis With Cyclophosphamide NCT00001155 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Assessment of Patients With Multiple Sclerosis (MS) NCT00001156 | National Institute of Neurological Disorders and Stroke (NINDS) | — |